In search of new compounds with strong antiproliferative activity and simple molecular structure, we designed a novel series of agents based on the 2-amino-3-alkoxycarbonyl/cyano-5-arylethylthiophene scaffold. The presence of the ethyl spacer between the 2',5'-dimethoxyphenyl and the 5-position of the thiophene ring, as well as the number and location of methoxy substitutents on the phenyl ring, played a profound role in affecting the antiproliferative activity. Among the synthesized compounds, we identified the 2-amino-3-cyano-[2-(2,5-dimethoxyphenyl)ethyl] thiophene 2c as the most promising derivative against a wide panel of cancer cell lines (IC 50 =17-130 nM). The antiproliferative activity of this compound appears to correlate well with its ability to inhibit tubulin assembly and the binding of colchicine to tubulin. Moreover 2c, as determined by flow cytometry, strongly induced arrest in the G2/M phase of the cell cycle, and annexin-V and propidium iodide staining indicate that cell death proceeds through an apoptotic mechanism that follows the intrinsic mitochondrial pathway.
Introduction
Microtubules are one of the three components of the cytoskeleton and are involved in a wide range of cellular functions critical for the life cycle of the cell. These include most notably cell division, where they form the mitotic spindle formation required for proper chromosomal separation. [1] [2] [3] The microtubule system is also important in other fundamental cellular processes, such as regulation of motility, cell signaling, formation and maintenance of cell shape, secretion and intracellular transport. 4 Research oriented toward the discovery of naturally occurring and synthetic molecules that bind to tubulin and disrupt microtubule dynamics have attracted considerable attention in the last few decades, since microtubules are a validated and important pharmacological target in cancer chemotherapy. [5] [6] [7] [8] Among synthetic small molecule tubulin inhibitors, Novartis Pharmaceuticals Corporation identified a new chemical entity as an anticancer agent, named SDZ LAP 977 (1, Chart 1).
This compound contains two fragments, the methyl ester of salicylic acid and, at its 5-position, a 2',5'-dimethoxyphenylethyl moiety. [9] [10] Compound 1 is active at low micromolar concentrations as an antiproliferative agent against both human pancreatic tumor (MIA PaCa-2) and epithelial carcinoma (A431) cells, blocking the cell cycle in mitosis through inhibition of tubulin polymerization.
The classical bioisosteric equivalence between benzene and thiophene prompted us to synthesize a series of 2-amino-3,5-disubstituted thiophene derivatives with general formula 2, in which a 2-aminothiophene system bearing at its 3-position a methoxycarbonyl, ethoxycarbonyl or cyano group replaced the salicylic acid methyl ester of compound 1. In this regards, replacement of an hydroxyl with an amino group furnished encouraging results in terms of significantly increased cytotoxicity against many human cancer lines in a series of benzophenone-type CA-4 analogues named phenstatins.
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Keeping constant the 2',5'-dimethoxyphenylethyl pharmacophore of 1 at the C-5 position of the thiophene ring, compounds 2a-c were designed in order to probe the importance of the substituent at the C-3 position, by the introduction of methoxycarbonyl (2a), ethoxycarbonyl (2b) and cyano (2c) groups. By the synthesis of 3,4-disubstituted derivatives 2d and 2e, we also evaluated the effect on activity caused by the concomitant presence of a methyl or ethoxycarbonyl at the C-4 position of the thiophene core in compounds 2a and 2b, respectively.
The building block intermediates 5a-e, coupled by the Sonogashira cross-coupling reaction with the appropriate terminal arylacetylene 13 In summary, using the biospheric thiophene ring to replace the second phenyl ring of compound 1, we synthesized a potent new agent with amino and nitrile substituents at positions C-2 and C-3, respectively. Thus far, additional manipulations of the basic structure of compound 2c have only resulted in much less active compounds. values obtained ranging from 12 to 86 nM ( Table 2 ). The greatest activity was observed with Jurkat, the least activity with MT4 both two T-leukemia cell lines. Such discrepancies in antitubulin versus antiproliferative activity are not infrequently observed, but the reasons are usually uncertain, as is the case here. Among possible explanations is that we are using bovine brain tubulin in the former studies, and its composition in terms of tubulin isotypes differs significantly from that of different human cancer cell lines. 15 The most active compounds in the in vitro tubulin polymerization assay were also evaluated for their effects on the binding of [ 3 H]colchicine to tubulin. 16 In this assay, derivative 2c
potently inhibited the binding of [ 3 H]colchicine to tubulin, and with 84% inhibition was 1.5-fold more active than 1, which in this experiment inhibited colchicines binding by 52%.
Inhibition of colchicine binding by compounds 2a and 2b was also lower than inhibition by 2c, but comparable to inhibition by 1. For the highly active 2c, a good correlation was observed between antiproliferative activity, inhibition of tubulin polymerization and inhibition of colchicine binding. These results indicate that an interaction with tubulin is a major cause of the antiproliferative activity of this group of compounds. Table 3 should be inserted here 3.4. Molecular Modeling. A series of molecular modeling simulations were performed to investigate the structural basis of the findings described above. The in silico studies were focused on understanding the role of the substitution pattern on the phenyl ring as well as the replacement of the ester with a nitrile group in the binding of these analogues to tubulin.
Initially, we performed a series of molecular docking calculations, which resulted in a suggested binding mode for this class of compounds very similar to the one reported in literature for several other colchicines site compounds. 17 In particular, all the compounds were placed with the phenyl ring in proximity of Cys241 and with the amino group within hydrogen-bond distance of αThr179. However, as shown in Fig. 1 , the docking software also predicted virtually the same binding pose for inactive compounds like 2f, and therefore our initial modeling studies did not provide a plausible justification for the empirical data obtained. For this reason, we performed a set of molecular dynamics (MD) simulations on the complexes between tubulin and three representative compounds of the series 2a, 2c and 2f.
The results obtained gave more detailed insight into a possible binding mechanism for these molecules. The most active compound in the series, 2c, was stable during the 3ns MD, with the phenyl ring always interacting with the Cys241 (see Supplementary Data) and forming a stable hydrogen bond with αThr179 (82% rate of formation). Furthermore, the 2-aminothiophene moiety maintained a close contact with Asn258 (Fig. 2) . Compound 2a also maintained a close contact with Cys241, but the hydrogen bond with αThr179 was less stable (22% rate of formation). Interestingly, the interaction of 2a with Asn258 seemed to be affected, possibly because of increased steric hindrance by the ester methyl group. Finally, in the case of 2f, the binding pose was significantly less stable (see Supporting Information).
During the MD simulation, the compound moved away from both Cys241 and αThr179
(12% rate of formation of the hydrogen bond with the amino group of 2f). The interaction with Asn258 was also disrupted during the calculations. In summary, from the MD simulations it appears that the methoxy group in the meta position of the phenyl ring is important in locking the compounds into the binding pocket, while the stability of the hydrogen bond of the 2-aminothiophene moiety with αThr179, supported by the interaction with Asn258, is responsible for enhancing the activity of 2c relative to 2a and 2f. We next studied the association between 2c-induced G2/M arrest and alterations in expression of proteins that regulate cell division. Cell arrest at the prometaphase/metaphase to anaphase transition is normally regulated by the mitotic checkpoint. 18 The cdc2/cyclin B complex controls both entry into and exit from mitosis. Phosphorylation of cdc2 on Tyr15 and phosphorylation of cdc25C phosphatase on Ser216 negatively regulate the activation of the cdc2/cyclin B complex.
Thus, dephosphorylation of these proteins is needed to activate the cdc2/cyclin B complex.
cdc25C is a major phosphatase that dephosphorylates the site on cdc2 and autodephosphorylates itself. Phosphorylation of cdc25C directly stimulates both its phosphatase and autophosphatase activities, a condition necessary to activate cdc2/cyclin B on entry of cells into mitosis. [19] [20] As shown in Figure 3 (panel C) in HeLa cells, 2c at low concentrations (50 and 100 nM) caused a marked increase in cyclin B1 expression after both 24 and 48 h treatments. In addition, slower migrating forms of phosphatase cdc25C appeared at 24 h, indicating changes in the phosphorylation state of this protein, followed by the disappearance of both forms of cdc25C at 48 h. The phosphorylation of cdc25C directly stimulates its phosphatase activity, and this is necessary to activate cdc2/cyclin B on entry of cells into mitosis. 19, 20 In addition, we observed a dramatic de-phosphorylation of cdc2 (Tyr15), just after 24 h of treatment, which should result in inhibition of formation of the cdc2/cyclinB complex. Mitochondrial membrane depolarization is associated with mitochondrial production of ROS. 23 Therefore, we investigated whether ROS production increased after treatment with 2c.
We utilized two fluorescence indicators, HE and H 2 -DCFDA, as previously described. 24 The results presented in Figure 5 (Panels B and C) showed that 2c induced the production of significant amounts of ROS in comparison with control cells, which agrees with the previously described dissipation of  mt . Altogether, these results indicate that this compound induced apoptosis through the mitochondrial pathway. and their activation is mediated by various inducers. 25 Synthesized as proenzymes, caspases are themselves activated by specific proteolytic cleavage reactions. Caspases-2, -8, -9, and -10 are termed apical caspases and are usually the first to be activated in the apoptotic process.
Following their activation, they in turn activate effector caspases, in particular caspase-3.
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Following treatment of HeLa cells with compound 2c (50 and 100 nM), we observed an early activation of caspase-9 at 24 h, followed at 48 h by activation of caspase-3 and of the caspase-3 substrate PARP ( Figure 6 , Panel A). These results are in good agreement with the mitochondrial depolarization described above, indicating that 2c induces the apoptotic intrinsic (mitochondrial) apoptosis pathway.
We also examined whether the induction of apoptosis by 2c was associated with changes in the expression of two proteins of the Bcl-2 family (Bcl-2 and Mcl-1), since there is increasing evidence that they share the signaling pathways induced by antimicrotubule compounds.
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Our results showed ( Figure has been reported to regulate sensitivity to antimitotic drugs. 29 These findings indicate that 2c
is endowed with high antiproliferative activity and should be further investigated to determine its therapeutic potential. 
Experimental

General procedure A for the synthesis of compounds 4a-e.
To a suspension of thiophene derivatives 3a-e (5 mmol) in acetic acid (30 mL) was added phthalic anhydride (890 mg, 6 mmol). After stirring for 18 h at reflux, the solvent was evaporated and the residue dissolved in CH 2 Cl 2 (50 mL). The organic solution was washed with a saturated solution of NaHCO 3 (15 mL), water (10 mL) and brine (10 mL). The organic layer was dried and evaporated, and the residue was purified by flash chromatography on silica gel or by crystallization with petroleum ether to afford 4a-e.
Methyl 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)thiophene-3-carboxylate (4a).
Following general procedure A, the crude residue purified by flash chromatography using 
Ethyl 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)thiophene-3-carboxylate (4b).
Methyl 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-methylthiophene-3-carboxylate (4d).
Ethyl 5-bromo-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)thiophene-3-carboxylate (5b
5-Bromo-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)thiophene-3-carbonitrile (5c).
Following general procedure B, the crude residue purified by crystallization from petroleum ether, furnished 5c as a yellow solid (82% yield); mp 204-205 °C. and PdCl 2 (PPh 3 ) 2 (70 mg, 0.1 mmol) were then added to the solution, which was stirred at 80
°C for 16 h. The mixture was cooled to room temperature and filtered through celite. The celite was rinsed with dichloromethane, and the filtrate was concentrated in vacuo. The residue was fractionated between water (5 mL) and dichloromethane (15 mL). The organic layer was washed with brine (5 mL) and dried over Na 2 SO 4 , and the solvent was evaporated.
The crude material was purified by column chromatography on silica gel. 
(s, 1H), (m, 2H), (m, 2H). MS (ESI):
[M+1] + =415.2. 
Methyl 5-[(2,5-dimethoxyphenyl)ethynyl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-methylthiophene-3-carboxylate (7d
Diethyl 5-[(2,5-dimethoxyphenyl)ethynyl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)thiophene-3,4-dicarboxylate (7e
Methyl 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-[(4-methoxyphenyl) ethynyl]thiophene-3-carboxylate (7g
(m, 2H). MS (ESI): [M+1]
+ =418.1. 
Methyl 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-[(4-methoxy-2-methylphenyl) ethynyl]thiophene-3-carboxylate (7h
(s, 1H), (m, 2H), (m, 2H). MS (ESI): [M+1]
+ =432.1. 
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-[(2-methoxyphenyl
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-[(4-methoxyphenyl) ethynyl]thiophene-3-carbonitrile (7l
(m, 2H). MS (ESI): [M+1]
+ =385.1. 
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-(phenylethynyl) thiophene-3-carbonitrile (7m
General procedure E for the synthesis of compounds 8a-m and 2n-o.
A stirred suspension of a thiophene derivative 7a-m and 6a-b (1 mmol) and hydrazine monohydrate (60 L, 1.2 mmol, 1.2 equiv.) in abs. EtOH (10 mL) was refluxed for 1 h. The solvent was evaporated, and the residue was partitioned between dichloromethane (20 mL) and water (5 mL). The separated organic phase, washed with brine (5 mL) and dried over Na 2 SO 4 , was concentrated under reduced pressure to obtain a residue that was purified by column chromatography.
Methyl 2-amino-5-[(2,5-dimethoxyphenyl)ethynyl]thiophene-3-carboxylate (8a).
Following general procedure E, the crude residue purified by flash chromatography using 
Ethyl 2-amino-5-[(2,5-dimethoxyphenyl)ethynyl]thiophene-3-carboxylate (8b).
Following general procedure E, the crude residue purified by flash chromatography using ethyl acetate:petroleum ether 3:7 (v:v) for elution, furnished 8b as a yellow oil (85% yield). 
(m, 1H). MS (ESI):
[M+1] + =332.1.
Diethyl 2-amino-5-[(2,5-dimethoxyphenyl)ethynyl]thiophene-3,4-dicarboxylate (8e).
5.6.6.
Methyl-2-Amino-5-[(2-methoxyphenyl)ethynyl]thiophene-3-carboxylate (8f).
Following general procedure E, the crude residue purified by flash chromatography using ethyl acetate:petroleum ether 2:8 (v:v) for elution, furnished 8f as a yellow oil (82% yield).
5.6.7.
Methyl-2-amino-5-[(4-methoxyphenyl)ethynyl]thiophene-3-carboxylate (8g).
5.6.9.
Ethyl-2-amino-5-[(2-methoxyphenyl)ethynyl]thiophene-3-carboxylate (8i).
5.6.10.
Ethyl-2-amino-5-[(4-methoxyphenyl)ethynyl]thiophene-3-carboxylate (8j).
2H). MS (ESI):
[M+1] + =302.0.
2-Amino-5-[(2-methoxyphenyl)ethynyl]thiophene-3-carbonitrile (8k). Following
general procedure E, the crude residue purified by flash chromatography using ethyl acetate:petroleum ether 3:7 (v:v) for elution, furnished 8k as a brown oil (74% yield). 
2-Amino-5-(phenylethynyl)thiophene-3-carbonitrile (8m). Following general
procedure E, the crude residue purified by flash chromatography using ethyl acetate:petroleum 
Methyl 2-amino-5-[2-(2,5-dimethoxyphenyl)ethyl]thiophene-3-carboxylate (2a).
Following general procedure F, the crude residue purified by flash chromatography using 
Ethyl 2-amino-5-[2-(2,5-dimethoxyphenyl)ethyl]thiophene-3-carboxylate (2b).
Following general procedure F, the crude residue purified by flash chromatography using ethyl acetate:petroleum ether 3:7 (v:v) for elution, furnished 2b as a yellow oil (86% yield). 
Methyl 2-amino-5-[2-(2-methoxyphenyl)ethyl]thiophene-3-carboxylate (2f).
Following general procedure F, the crude residue purified by flash chromatography using ethyl acetate:petroleum ether 3:7 (v:v) for elution, furnished 2f as a yellow oil (87% yield). 
Methyl 2-amino-5-[2-(4-methoxyphenyl)ethyl]thiophene-3-carboxylate (2g).
Following general procedure F, the crude residue purified by flash chromatography using ethyl acetate:petroleum ether 2:8 (v:v) for elution, furnished 2g as a colorless oil (>95% 
Ethyl 2-amino-5-[2-(2-methoxyphenyl)ethyl]thiophene-3-carboxylate (2i).
Following general procedure F, the crude residue purified by flash chromatography using ethyl acetate:petroleum ether 2:8 (v:v) for elution, furnished 2i as a colorless oil (>95% yield). 
Ethyl 2-amino-5-[2-(4-methoxyphenyl)ethyl]thiophene-3-carboxylate (2j).
Biology Experiments
Antiproliferative assays.
Cancer cells were suspended at 300,000-500,000 cells/mL of culture medium, and 100 µL of a cell suspension was added to 100 µL of an appropriate dilution of the test compounds in wells of 96-well microtiter plates. After incubation at 37 °C for 48 h, cell number was determined using a Coulter counter. The IC 50 was defined as the compound concentration required to inhibit cell proliferation by 50%.
the effect of the compounds on tubulin assembly in vitro, 14 
Molecular Modeling.
All molecular modeling studies were performed on a MacPro dual 2.66GHz Xeon running Ubuntu 10. The tubulin structure was downloaded from the PDB data bank (http://www.rcsb.org/ -PDB code: 3HKC). 30 The 3HKC structure was chosen based on the structural similarities of the co-crystallized ligand present in this complex over the ligands present in other tubulin structures available. 17 Hydrogen atoms were added to the protein, using the Protonate3D function of Molecular Operating Environment (MOE).
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Ligand structures were built with MOE and minimized using the MMFF94x forcefield until a RMSD gradient of 0.05 kcal mol -1 Å -1 was reached. The docking simulations were performed using PLANTS. 32 Molecular dynamics was performed with the Gromacs 4.5 33 with the Amber99 force field. The structure was solvated using TIP3P water molecules, providing a minimum of 9.0 Å of water between the protein surface and any periodic box edge. The system was neutralized, minimized and then a position restrain dynamics simulation was carried out for 150 ps. The production simulation was conducted for 3 ns at 298 K using a NPT environment. Inhibitors were parameterized by Antechamber of AmberTool 1.5.
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Trajectories analysis were carried out by VMD. Simultaneously, the cells were stained with PI. Excitation was set at 488 nm, and the emission filters were at 525 and 585 nm, respectively, for FTIC and PI.
5.8.6. Assessment of mitochondrial changes. The mitochondrial membrane potential was measured with the lipophilic cationic dye JC-1 (Molecular Probes), as described. 24 The production of ROS was measured by flow cytometry using either HE (Molecular Probes) or H 2 DCFDA (Molecular Probes), as previously described. 
